Clonal-level Lineage Commitment Pathways of Hematopoietic Stem Cells in Vivo
Overview
Affiliations
While the aggregate differentiation of the hematopoietic stem cell (HSC) population has been extensively studied, little is known about the lineage commitment process of individual HSC clones. Here, we provide lineage commitment maps of HSC clones under homeostasis and after perturbations of the endogenous hematopoietic system. Under homeostasis, all donor-derived HSC clones regenerate blood homogeneously throughout all measured stages and lineages of hematopoiesis. In contrast, after the hematopoietic system has been perturbed by irradiation or by an antagonistic anti-ckit antibody, only a small fraction of donor-derived HSC clones differentiate. Some of these clones dominantly expand and exhibit lineage bias. We identified the cellular origins of clonal dominance and lineage bias and uncovered the lineage commitment pathways that lead HSC clones to different levels of self-renewal and blood production under various transplantation conditions. This study reveals surprising alterations in HSC fate decisions directed by conditioning and identifies the key hematopoiesis stages that may be manipulated to control blood production and balance.
Continuous map of early hematopoietic stem cell differentiation across human lifetime.
Komic H, Schmachtel T, Simoes C, Kulp M, Yu W, Jolly A Nat Commun. 2025; 16(1):2287.
PMID: 40055319 PMC: 11889232. DOI: 10.1038/s41467-025-57096-y.
Bentivegna S, Almosailleakh M, Zhao L, Schuster M, Benquet S, Balhuizen A Exp Hematol Oncol. 2025; 14(1):10.
PMID: 39885602 PMC: 11781034. DOI: 10.1186/s40164-025-00598-8.
Watt S, Roubelakis M Int J Mol Sci. 2025; 26(2).
PMID: 39859383 PMC: 11766050. DOI: 10.3390/ijms26020671.
Advancements in prospective single-cell lineage barcoding and their applications in research.
Zhang X, Huang Y, Yang Y, Wang Q, Li L Genome Res. 2024; 34(12):2147-2162.
PMID: 39572229 PMC: 11694748. DOI: 10.1101/gr.278944.124.
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy.
Bowman R, Dunbar A, Mishra T, Xiao W, Waarts M, Maestre I Cancer Cell. 2024; 42(11):1955-1969.e7.
PMID: 39532065 PMC: 11561369. DOI: 10.1016/j.ccell.2024.10.009.